Amussen Hunsaker & Associates LLC Buys Boeing Co, Vanguard High Dividend Yield Index Fund, SPDR S&P 500 ETF Trust, Sells Cimpress NV, Vanguard FTSE Emerging Markets ETF, Vanguard FTSE Developed Markets ETF

Author's Avatar
Nov 15, 2019
Article's Main Image
Investment company Amussen Hunsaker & Associates LLC (Current Portfolio) buys Boeing Co, Vanguard High Dividend Yield Index Fund, SPDR S&P 500 ETF Trust, NVIDIA Corp, Intel Corp, sells Cimpress NV, Vanguard FTSE Emerging Markets ETF, Vanguard FTSE Developed Markets ETF, iShares Nasdaq Biotechnology Index Fund, Vanguard Intermediate-Term Corporate Bond ETF during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Amussen Hunsaker & Associates LLC. As of 2019Q3, Amussen Hunsaker & Associates LLC owns 66 stocks with a total value of $159 million. These are the details of the buys and sells.

For the details of Amussen Hunsaker & Associates LLC's stock buys and sells, go to https://www.gurufocus.com/guru/amussen+hunsaker+%26+associates+llc/current-portfolio/portfolio

These are the top 5 holdings of Amussen Hunsaker & Associates LLC
  1. Johnson & Johnson (JNJ) - 142,872 shares, 11.61% of the total portfolio. Shares added by 7.67%
  2. Berkshire Hathaway Inc (BRK.B) - 83,384 shares, 10.89% of the total portfolio. Shares added by 3.80%
  3. Apple Inc (AAPL) - 69,080 shares, 9.71% of the total portfolio. Shares added by 6.71%
  4. American Express Co (AXP) - 96,469 shares, 7.16% of the total portfolio. Shares added by 8.16%
  5. The Walt Disney Co (DIS) - 84,212 shares, 6.89% of the total portfolio. Shares reduced by 1.21%
New Purchase: Intel Corp (INTC)

Amussen Hunsaker & Associates LLC initiated holding in Intel Corp. The purchase prices were between $44.96 and $53.01, with an estimated average price of $49.13. The stock is now traded at around $57.81. The impact to a portfolio due to this purchase was 0.25%. The holding were 7,660 shares as of .

New Purchase: SPDR S&P Dividend ETF (SDY)

Amussen Hunsaker & Associates LLC initiated holding in SPDR S&P Dividend ETF. The purchase prices were between $96.69 and $103.8, with an estimated average price of $100.83. The stock is now traded at around $105.63. The impact to a portfolio due to this purchase was 0.23%. The holding were 3,552 shares as of .

New Purchase: ALLETE Inc (ALE)

Amussen Hunsaker & Associates LLC initiated holding in ALLETE Inc. The purchase prices were between $82.99 and $88.17, with an estimated average price of $86.05. The stock is now traded at around $80.90. The impact to a portfolio due to this purchase was 0.16%. The holding were 2,829 shares as of .

New Purchase: Verizon Communications Inc (VZ)

Amussen Hunsaker & Associates LLC initiated holding in Verizon Communications Inc. The purchase prices were between $55.05 and $60.51, with an estimated average price of $57.61. The stock is now traded at around $59.34. The impact to a portfolio due to this purchase was 0.16%. The holding were 4,095 shares as of .

New Purchase: Campbell Soup Co (CPB)

Amussen Hunsaker & Associates LLC initiated holding in Campbell Soup Co. The purchase prices were between $40.12 and $47.15, with an estimated average price of $43.18. The stock is now traded at around $47.07. The impact to a portfolio due to this purchase was 0.14%. The holding were 4,800 shares as of .

New Purchase: Allstate Corp (ALL)

Amussen Hunsaker & Associates LLC initiated holding in Allstate Corp. The purchase prices were between $101.21 and $108.68, with an estimated average price of $104.33. The stock is now traded at around $110.80. The impact to a portfolio due to this purchase was 0.13%. The holding were 1,854 shares as of .

Added: Boeing Co (BA)

Amussen Hunsaker & Associates LLC added to a holding in Boeing Co by 143.01%. The purchase prices were between $320.42 and $386.89, with an estimated average price of $357.51. The stock is now traded at around $367.44. The impact to a portfolio due to this purchase was 2.3%. The holding were 16,313 shares as of .

Added: Vanguard High Dividend Yield Index Fund (VYM)

Amussen Hunsaker & Associates LLC added to a holding in Vanguard High Dividend Yield Index Fund by 656.80%. The purchase prices were between $83.9 and $89.75, with an estimated average price of $87.52. The stock is now traded at around $90.99. The impact to a portfolio due to this purchase was 1.08%. The holding were 22,318 shares as of .

Added: SPDR S&P 500 ETF Trust (SPY)

Amussen Hunsaker & Associates LLC added to a holding in SPDR S&P 500 ETF Trust by 65.92%. The purchase prices were between $282.52 and $300.62, with an estimated average price of $294.27. The stock is now traded at around $309.55. The impact to a portfolio due to this purchase was 0.81%. The holding were 10,982 shares as of .

Added: NVIDIA Corp (NVDA)

Amussen Hunsaker & Associates LLC added to a holding in NVIDIA Corp by 140.22%. The purchase prices were between $148.77 and $184.33, with an estimated average price of $168.17. The stock is now traded at around $209.79. The impact to a portfolio due to this purchase was 0.45%. The holding were 7,024 shares as of .

Added: Caterpillar Inc (CAT)

Amussen Hunsaker & Associates LLC added to a holding in Caterpillar Inc by 150.00%. The purchase prices were between $113.38 and $139.64, with an estimated average price of $127.06. The stock is now traded at around $143.44. The impact to a portfolio due to this purchase was 0.24%. The holding were 5,000 shares as of .

Added: Pfizer Inc (PFE)

Amussen Hunsaker & Associates LLC added to a holding in Pfizer Inc by 140.15%. The purchase prices were between $34.24 and $44.4, with an estimated average price of $38.38. The stock is now traded at around $36.55. The impact to a portfolio due to this purchase was 0.2%. The holding were 15,199 shares as of .

Sold Out: Vanguard FTSE Emerging Markets ETF (VWO)

Amussen Hunsaker & Associates LLC sold out a holding in Vanguard FTSE Emerging Markets ETF. The sale prices were between $39 and $43.14, with an estimated average price of $41.29.

Sold Out: iShares Nasdaq Biotechnology Index Fund (IBB)

Amussen Hunsaker & Associates LLC sold out a holding in iShares Nasdaq Biotechnology Index Fund. The sale prices were between $99.3 and $110.93, with an estimated average price of $104.75.

Sold Out: Health Care Select Sector SPDR Fund (XLV)

Amussen Hunsaker & Associates LLC sold out a holding in Health Care Select Sector SPDR Fund. The sale prices were between $88.76 and $94.4, with an estimated average price of $91.34.

Sold Out: AT&T Inc (T)

Amussen Hunsaker & Associates LLC sold out a holding in AT&T Inc. The sale prices were between $32.09 and $38.74, with an estimated average price of $35.06.

Sold Out: Nuveen California Quality Municipal Income Fund (NAC)

Amussen Hunsaker & Associates LLC sold out a holding in Nuveen California Quality Municipal Income Fund. The sale prices were between $14.25 and $15.49, with an estimated average price of $14.88.

Sold Out: Galectin Therapeutics Inc (GALT)

Amussen Hunsaker & Associates LLC sold out a holding in Galectin Therapeutics Inc. The sale prices were between $3 and $4.05, with an estimated average price of $3.62.



Here is the complete portfolio of Amussen Hunsaker & Associates LLC. Also check out:

1. Amussen Hunsaker & Associates LLC's Undervalued Stocks
2. Amussen Hunsaker & Associates LLC's Top Growth Companies, and
3. Amussen Hunsaker & Associates LLC's High Yield stocks
4. Stocks that Amussen Hunsaker & Associates LLC keeps buying